First diagnoses | A (n = 48) | B (n = 41) | C (n = 32) | p-value* | Adjusted p-value |
---|---|---|---|---|---|
Prescription of specific anti-dementia drug (independent of guideline)§ | 14 (29.2%) | 15 (36.6%) | 12 (37.5%) | .6711 | .857 |
First diagnoses with purely vascular dementia | A (n = 10) | B (n = 10) | C (n = 10) | ||
No cholinesterase inhibitor/Memantine in purely vascular dementia (in conformity with guideline) | 4 (40.0%) | 7 (70.0%) | 9 (90.0%) | .0582 | .071 |
First diagnoses with mild dementia with specific anti-dementia treatment | A (n = 11) | B (n = 12) | C (n = 9) | ||
No Memantine in mild dementia (in conformity with guideline) | 6 (54.5%) | 10 (83.3%) | 6 (66.7%) | .3263 | .477 |